Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

This study has been completed.
Teva Pharma
Information provided by (Responsible Party):
Kyowa Hakko Kirin Pharma, Inc. Identifier:
First received: September 30, 2011
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)